Harbor Healthcare Consultants, a leading pharmacy mergers and acquisitions advisory firm founded by pharmacist Ira Cammeyer, is pleased to announce the successful sale of a premier 503A compounding pharmacy accredited for sterile and non-sterile formulations. Licensed in 12 states across the mid-Atlantic, The Compounding Center, originally established in 1976, built an exceptional reputation for quality and safety, earning multiple accreditations and compliance with USP <795/797>, and <800> guidelines. This transaction marks a significant milestone for both buyer and seller. The owners worked hard to create an exceptional business and realized the acquirer put forward synergies that gave them confidence that the legacy of the business and the team would continue to flourish. For the buyer, the acquisition represented a strategic opportunity to expand geographically into new territories and better serve many of their existing customers.
Mark Alford, Managing Director at Harbor Healthcare Consultants, commented, “We are thrilled about the pivotal role we played in helping the sellers achieve their dreams and move onto the next phase in their lives. Their unwavering commitment to excellence and their distinguished accreditations made them an ideal partner for the buyer. We’re excited to watch this partnership benefit patients and the broader healthcare community.”
Cheri Garvin, President and CEO of The Compounding Center added, “We are excited to join forces with a company that shares our dedication to quality and innovation in compounding pharmacy services. This acquisition allows the pharmacy to expand its reach and continue providing patients and providers with the highest level of care. We are confident that our shared values and combined expertise will lead to even greater success.”
“Acquiring this well-established and respected compounding pharmacy is a strategic move that strengthens our presence in the mid-Atlantic region,” said the CEO of the acquirer. “We are committed to maintaining the high standards of quality and service that this pharmacy is known for, and we look forward to the opportunities this acquisition brings to enhance our offerings and better serve our patients nationwide.”
Harbor Healthcare acted as the exclusive sell-side advisor to the sellers. The acquisition underscores the growth potential and strategic value of high-quality, accredited compounding pharmacies in the evolving healthcare landscape.
About The Compounding Center
A 503A Compounding Pharmacy, The Compounding Center has been serving the community for over 45 years with all medication specialties from Urology to Functional Medicine to Veterinary preparations and everything in between. The pharmacy, licensed in 12 states, was the first PCAB Accredited Pharmacy in the DC area to achieve this recognition in both sterile and non-sterile compounding.
About the Acquiring Pharmacy
The acquirer is a 503A compounding pharmacy specializing in a variety of compounded dosage forms in sterile and non-sterile environments. By providing better patient outcomes through quality compounding, they remain at the nationwide forefront of the compounding pharmacy segment. The pharmacy is licensed in nearly all 50 states and provides medication for anti-aging and integrative therapies.
About Harbor Healthcare
Harbor Healthcare is a boutique M&A advisory firm founded in 1995 by its President and pharmacist, Ira Cammeyer. Harbor offers a variety of M&A advisory services to middle market healthcare and pharmacy businesses. The company provides perceptive strategic solutions to independent owners and investors of long-term care, specialty, infusion, compounding and 340B pharmacies. Harbor offers regulatory and advisory expertise while maintaining business relationships with strategic, private equity and independent acquirers. For more information, please contact Mark Alford, Managing Director at Harbor Healthcare (619) 535-9005 or visit https://www.harborhealthcare.com.
Click Here for a Sample of Our M&A Transactions
Select Transactions